FDA inspection
Pfizer Asia Pacific Pte Ltd.: FDA inspection ending Mar 15, 2019
FDA inspection 1085293 · Singapore
Key facts
| Inspection ID | 1085293 |
|---|---|
| Firm | Pfizer Asia Pacific Pte Ltd. |
| FEI number | 3003901862 |
| Address | 31 Tuas South Avenue 6 |
| City | Singapore |
| Fiscal year | 2019 |
| Inspection end date | Mar 15, 2019 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data